In summary, we found that the NEAT1 expression promoters angiogenesis in HUVECs under BS patient serum treatment by regulating miR‐495‐3p and activating the TGF‐β1/SMAD signaling pathway. The gene discussed is TGFB1; the disease is Bloom syndrome.